Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Microneedle Flu Vaccine Market Growth 2022-2028

  • LP 4883414
  • 95 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Microneedle Flu Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Microneedle Flu Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Microneedle Flu Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Microneedle Flu Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Microneedle Flu Vaccine market, reaching US$ million by the year 2028. As for the Europe Microneedle Flu Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Microneedle Flu Vaccine players cover Sanofi, GC Pharma, Debiotech, and NanoPass Technologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Microneedle Flu Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Solid Microneedle

Hollow Microneedle

Coated Microneedle

Dissolving Microneedle

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Influenza A

Influenza B

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi

GC Pharma

Debiotech

NanoPass Technologies

Corium International

Becton Dickinson and Company

FluGen

CosMED Pharmaceuticals

Microdermics and OraSure Technologies

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Microneedle Flu Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Microneedle Flu Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Microneedle Flu Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Microneedle Flu Vaccine Segment by Type

2.2.1 Solid Microneedle

2.2.2 Hollow Microneedle

2.2.3 Coated Microneedle

2.2.4 Dissolving Microneedle

2.3 Microneedle Flu Vaccine Sales by Type

2.3.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Microneedle Flu Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Microneedle Flu Vaccine Sale Price by Type (2017-2022)

2.4 Microneedle Flu Vaccine Segment by Application

2.4.1 Influenza A

2.4.2 Influenza B

2.5 Microneedle Flu Vaccine Sales by Application

2.5.1 Global Microneedle Flu Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Microneedle Flu Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Microneedle Flu Vaccine Sale Price by Application (2017-2022)

3 Global Microneedle Flu Vaccine by Company

3.1 Global Microneedle Flu Vaccine Breakdown Data by Company

3.1.1 Global Microneedle Flu Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Microneedle Flu Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Microneedle Flu Vaccine Revenue by Company (2020-2022)

3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Microneedle Flu Vaccine Sale Price by Company

3.4 Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Microneedle Flu Vaccine Product Location Distribution

3.4.2 Players Microneedle Flu Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Microneedle Flu Vaccine by Geographic Region

4.1 World Historic Microneedle Flu Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Microneedle Flu Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Microneedle Flu Vaccine Annual Revenue by Geographic Region

4.2 World Historic Microneedle Flu Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Microneedle Flu Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Microneedle Flu Vaccine Annual Revenue by Country/Region

4.3 Americas Microneedle Flu Vaccine Sales Growth

4.4 APAC Microneedle Flu Vaccine Sales Growth

4.5 Europe Microneedle Flu Vaccine Sales Growth

4.6 Middle East & Africa Microneedle Flu Vaccine Sales Growth

5 Americas

5.1 Americas Microneedle Flu Vaccine Sales by Country

5.1.1 Americas Microneedle Flu Vaccine Sales by Country (2017-2022)

5.1.2 Americas Microneedle Flu Vaccine Revenue by Country (2017-2022)

5.2 Americas Microneedle Flu Vaccine Sales by Type

5.3 Americas Microneedle Flu Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Microneedle Flu Vaccine Sales by Region

6.1.1 APAC Microneedle Flu Vaccine Sales by Region (2017-2022)

6.1.2 APAC Microneedle Flu Vaccine Revenue by Region (2017-2022)

6.2 APAC Microneedle Flu Vaccine Sales by Type

6.3 APAC Microneedle Flu Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Microneedle Flu Vaccine by Country

7.1.1 Europe Microneedle Flu Vaccine Sales by Country (2017-2022)

7.1.2 Europe Microneedle Flu Vaccine Revenue by Country (2017-2022)

7.2 Europe Microneedle Flu Vaccine Sales by Type

7.3 Europe Microneedle Flu Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Microneedle Flu Vaccine by Country

8.1.1 Middle East & Africa Microneedle Flu Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Microneedle Flu Vaccine Sales by Type

8.3 Middle East & Africa Microneedle Flu Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine

10.3 Manufacturing Process Analysis of Microneedle Flu Vaccine

10.4 Industry Chain Structure of Microneedle Flu Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Microneedle Flu Vaccine Distributors

11.3 Microneedle Flu Vaccine Customer

12 World Forecast Review for Microneedle Flu Vaccine by Geographic Region

12.1 Global Microneedle Flu Vaccine Market Size Forecast by Region

12.1.1 Global Microneedle Flu Vaccine Forecast by Region (2023-2028)

12.1.2 Global Microneedle Flu Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Microneedle Flu Vaccine Forecast by Type

12.7 Global Microneedle Flu Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Microneedle Flu Vaccine Product Offered

13.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 GC Pharma

13.2.1 GC Pharma Company Information

13.2.2 GC Pharma Microneedle Flu Vaccine Product Offered

13.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GC Pharma Main Business Overview

13.2.5 GC Pharma Latest Developments

13.3 Debiotech

13.3.1 Debiotech Company Information

13.3.2 Debiotech Microneedle Flu Vaccine Product Offered

13.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Debiotech Main Business Overview

13.3.5 Debiotech Latest Developments

13.4 NanoPass Technologies

13.4.1 NanoPass Technologies Company Information

13.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Offered

13.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 NanoPass Technologies Main Business Overview

13.4.5 NanoPass Technologies Latest Developments

13.5 Corium International

13.5.1 Corium International Company Information

13.5.2 Corium International Microneedle Flu Vaccine Product Offered

13.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Corium International Main Business Overview

13.5.5 Corium International Latest Developments

13.6 Becton Dickinson and Company

13.6.1 Becton Dickinson and Company Company Information

13.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Offered

13.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Becton Dickinson and Company Main Business Overview

13.6.5 Becton Dickinson and Company Latest Developments

13.7 FluGen

13.7.1 FluGen Company Information

13.7.2 FluGen Microneedle Flu Vaccine Product Offered

13.7.3 FluGen Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 FluGen Main Business Overview

13.7.5 FluGen Latest Developments

13.8 CosMED Pharmaceuticals

13.8.1 CosMED Pharmaceuticals Company Information

13.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Offered

13.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CosMED Pharmaceuticals Main Business Overview

13.8.5 CosMED Pharmaceuticals Latest Developments

13.9 Microdermics and OraSure Technologies

13.9.1 Microdermics and OraSure Technologies Company Information

13.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Offered

13.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Microdermics and OraSure Technologies Main Business Overview

13.9.5 Microdermics and OraSure Technologies Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Microneedle Flu Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Microneedle Flu Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Solid Microneedle

Table 4. Major Players of Hollow Microneedle

Table 5. Major Players of Coated Microneedle

Table 6. Major Players of Dissolving Microneedle

Table 7. Global Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)

Table 8. Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)

Table 9. Global Microneedle Flu Vaccine Revenue by Type (2017-2022) & ($ million)

Table 10. Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2022)

Table 11. Global Microneedle Flu Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)

Table 13. Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)

Table 14. Global Microneedle Flu Vaccine Revenue by Application (2017-2022)

Table 15. Global Microneedle Flu Vaccine Revenue Market Share by Application (2017-2022)

Table 16. Global Microneedle Flu Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Microneedle Flu Vaccine Sales by Company (2020-2022) & (K Units)

Table 18. Global Microneedle Flu Vaccine Sales Market Share by Company (2020-2022)

Table 19. Global Microneedle Flu Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Microneedle Flu Vaccine Revenue Market Share by Company (2020-2022)

Table 21. Global Microneedle Flu Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution and Sales Area

Table 23. Players Microneedle Flu Vaccine Products Offered

Table 24. Microneedle Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Microneedle Flu Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Microneedle Flu Vaccine Sales Market Share Geographic Region (2017-2022)

Table 29. Global Microneedle Flu Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Microneedle Flu Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Microneedle Flu Vaccine Sales Market Share by Country/Region (2017-2022)

Table 33. Global Microneedle Flu Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Microneedle Flu Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)

Table 36. Americas Microneedle Flu Vaccine Sales Market Share by Country (2017-2022)

Table 37. Americas Microneedle Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Microneedle Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 39. Americas Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)

Table 40. Americas Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)

Table 41. Americas Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)

Table 42. Americas Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)

Table 43. APAC Microneedle Flu Vaccine Sales by Region (2017-2022) & (K Units)

Table 44. APAC Microneedle Flu Vaccine Sales Market Share by Region (2017-2022)

Table 45. APAC Microneedle Flu Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Microneedle Flu Vaccine Revenue Market Share by Region (2017-2022)

Table 47. APAC Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)

Table 48. APAC Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)

Table 49. APAC Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)

Table 50. APAC Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)

Table 51. Europe Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)

Table 52. Europe Microneedle Flu Vaccine Sales Market Share by Country (2017-2022)

Table 53. Europe Microneedle Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 55. Europe Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)

Table 56. Europe Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)

Table 57. Europe Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)

Table 58. Europe Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Microneedle Flu Vaccine

Table 68. Key Market Challenges & Risks of Microneedle Flu Vaccine

Table 69. Key Industry Trends of Microneedle Flu Vaccine

Table 70. Microneedle Flu Vaccine Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Microneedle Flu Vaccine Distributors List

Table 73. Microneedle Flu Vaccine Customer List

Table 74. Global Microneedle Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Microneedle Flu Vaccine Sales Market Forecast by Region

Table 76. Global Microneedle Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Microneedle Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Microneedle Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Microneedle Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Microneedle Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Microneedle Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Microneedle Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Microneedle Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Microneedle Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Microneedle Flu Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Microneedle Flu Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Microneedle Flu Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Microneedle Flu Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Microneedle Flu Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 94. Sanofi Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 95. Sanofi Microneedle Flu Vaccine Product Offered

Table 96. Sanofi Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Sanofi Main Business

Table 98. Sanofi Latest Developments

Table 99. GC Pharma Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 100. GC Pharma Microneedle Flu Vaccine Product Offered

Table 101. GC Pharma Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. GC Pharma Main Business

Table 103. GC Pharma Latest Developments

Table 104. Debiotech Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 105. Debiotech Microneedle Flu Vaccine Product Offered

Table 106. Debiotech Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Debiotech Main Business

Table 108. Debiotech Latest Developments

Table 109. NanoPass Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 110. NanoPass Technologies Microneedle Flu Vaccine Product Offered

Table 111. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. NanoPass Technologies Main Business

Table 113. NanoPass Technologies Latest Developments

Table 114. Corium International Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 115. Corium International Microneedle Flu Vaccine Product Offered

Table 116. Corium International Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Corium International Main Business

Table 118. Corium International Latest Developments

Table 119. Becton Dickinson and Company Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 120. Becton Dickinson and Company Microneedle Flu Vaccine Product Offered

Table 121. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Becton Dickinson and Company Main Business

Table 123. Becton Dickinson and Company Latest Developments

Table 124. FluGen Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 125. FluGen Microneedle Flu Vaccine Product Offered

Table 126. FluGen Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. FluGen Main Business

Table 128. FluGen Latest Developments

Table 129. CosMED Pharmaceuticals Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 130. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Offered

Table 131. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. CosMED Pharmaceuticals Main Business

Table 133. CosMED Pharmaceuticals Latest Developments

Table 134. Microdermics and OraSure Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 135. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Offered

Table 136. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Microdermics and OraSure Technologies Main Business

Table 138. Microdermics and OraSure Technologies Latest Developments

List of Figures

Figure 1. Picture of Microneedle Flu Vaccine

Figure 2. Microneedle Flu Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Microneedle Flu Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Microneedle Flu Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Microneedle Flu Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Solid Microneedle

Figure 10. Product Picture of Hollow Microneedle

Figure 11. Product Picture of Coated Microneedle

Figure 12. Product Picture of Dissolving Microneedle

Figure 13. Global Microneedle Flu Vaccine Sales Market Share by Type in 2021

Figure 14. Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2022)

Figure 15. Microneedle Flu Vaccine Consumed in Influenza A

Figure 16. Global Microneedle Flu Vaccine Market: Influenza A (2017-2022) & (K Units)

Figure 17. Microneedle Flu Vaccine Consumed in Influenza B

Figure 18. Global Microneedle Flu Vaccine Market: Influenza B (2017-2022) & (K Units)

Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Application in 2021

Figure 21. Microneedle Flu Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Microneedle Flu Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Microneedle Flu Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Microneedle Flu Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Microneedle Flu Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Microneedle Flu Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Microneedle Flu Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Microneedle Flu Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Microneedle Flu Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Microneedle Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Microneedle Flu Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Microneedle Flu Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Microneedle Flu Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Microneedle Flu Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Microneedle Flu Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Microneedle Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Microneedle Flu Vaccine

Figure 65. Industry Chain Structure of Microneedle Flu Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390